Viewing StudyNCT00027261



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00027261
Status: COMPLETED
Last Update Posted: 2021-10-14
First Post: 2001-11-29

Brief Title: Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy HIV Uninfected Adults
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
HIV Seronegativity
HIV Infections
Keywords:
Name View
Vaccines Synthetic View
HIV-1 View
AIDS Vaccines View
CD8-Positive T-Lymphocytes View
HIV Seronegativity View
Avipoxvirus View
Dose-Response Relationship Immunologic View
HIV Preventive Vaccine View